REQUEST A DEMO
Total
USD $0.00
Search more companies

Improhosfar S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Improhosfar S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Improhosfar S.A. is based in Ecuador, with the head office in Guayaquil. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on April 01, 2002. There are currently 10 (2024) people employed by Improhosfar S.A.. From the latest financial highlights, Improhosfar S.A. reported a net sales revenue drop of 14.17% in 2024. During that time, Improhosfar S.A.’s total assets grew by 20.97%.

Headquarters
Calle e 302
Guayaquil; Guayas;

Contact Details: Purchase the Improhosfar S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Improhosfar S.A. report to view the information.
Registered Capital:
Purchase the Improhosfar S.A. report to view the information.
Financial Auditors:
Purchase the Improhosfar S.A. report to view the information.
Incorporation Date:
April 01, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50.02%
Purchase this report to view the information.
49.98%
Subsidiaries
Improhosfar S.A.
50.02%
Company Performance
Financial values in the chart are available after Improhosfar S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.17%
Total operating revenue
-12.48%
Operating profit (EBIT)
175.54%
EBITDA
106.94%
Net Profit (Loss) for the Period
N/A
Total assets
20.97%
Total equity
2.9%
Operating Profit Margin (ROS)
3.43%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-4.84%
Quick Ratio
-0.06%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?